Multi-AD: Cross-Domain Unsupervised Anomaly Detection for Medical and Industrial Applications

Traditional deep learning models often lack annotated data, especially in cross-domain applications such as anomaly detection, which is critical for early disease diagnosis in medicine and defect detection in industry. To address this challenge, we propose Multi-AD, a convolutional neural network (CNN) model for robust unsupervised anomaly detection across medical and industrial images. Our approach employs the squeeze-and-excitation (SE) block to enhance feature extraction via channel-wise attention, enabling the model to focus on the most relevant features and detect subtle anomalies. Knowledge distillation (KD) transfers informative features from the teacher to the student model, enabling effective learning of the differences between normal and anomalous data. Then, the discriminator network further enhances the model's capacity to distinguish between normal and anomalous data. At the inference stage, by integrating multi-scale features, the student model can detect anomalies of varying sizes. The teacher-student (T-S) architecture ensures consistent representation of high-dimensional features while adapting them to enhance anomaly detection. Multi-AD was evaluated on several medical datasets, including brain MRI, liver CT, and retina OCT, as well as industrial datasets, such as MVTec AD, demonstrating strong generalization across multiple domains. Experimental results demonstrated that our approach consistently outperformed state-of-the-art models, achieving the best average AUROC for both image-level (81.4% for medical and 99.6% for industrial) and pixel-level (97.0% for medical and 98.4% for industrial) tasks, making it effective for real-world applications.

Towards Segmenting the Invisible: An End-to-End Registration and Segmentation Framework for Weakly Supervised Tumour Analysis

Liver tumour ablation presents a significant clinical challenge: whilst tumours are clearly visible on pre-operative MRI, they are often effectively invisible on intra-operative CT due to minimal contrast between pathological and healthy tissue. This work investigates the feasibility of cross-modality weak supervision for scenarios where pathology is visible in one modality (MRI) but absent in another (CT). We present a hybrid registration-segmentation framework that combines MSCGUNet for inter-modal image registration with a UNet-based segmentation module, enabling registration-assisted pseudo-label generation for CT images. Our evaluation on the CHAOS dataset demonstrates that the pipeline can successfully register and segment healthy liver anatomy, achieving a Dice score of 0.72. However, when applied to clinical data containing tumours, performance degrades substantially (Dice score of 0.16), revealing the fundamental limitations of current registration methods when the target pathology lacks corresponding visual features in the target modality. We analyse the "domain gap" and "feature absence" problems, demonstrating that whilst spatial propagation of labels via registration is feasible for visible structures, segmenting truly invisible pathology remains an open challenge. Our findings highlight that registration-based label transfer cannot compensate for the absence of discriminative features in the target modality, providing important insights for future research in cross-modality medical image analysis. Code an weights are available at: https://github.com/BudhaTronix/Weakly-Supervised-Tumour-Detection

Toxicity Assessment in Preclinical Histopathology via Class-Aware Mahalanobis Distance for Known and Novel Anomalies

Drug-induced toxicity remains a leading cause of failure in preclinical development and early clinical trials. Detecting adverse effects at an early stage is critical to reduce attrition and accelerate the development of safe medicines. Histopathological evaluation remains the gold standard for toxicity assessment, but it relies heavily on expert pathologists, creating a bottleneck for large-scale screening. To address this challenge, we introduce an AI-based anomaly detection framework for histopathological whole-slide images (WSIs) in rodent livers from toxicology studies. The system identifies healthy tissue and known pathologies (anomalies) for which training data is available. In addition, it can detect rare pathologies without training data as out-of-distribution (OOD) findings. We generate a novel dataset of pixelwise annotations of healthy tissue and known pathologies and use this data to fine-tune a pre-trained Vision Transformer (DINOv2) via Low-Rank Adaptation (LoRA) in order to do tissue segmentation. Finally, we extract features for OOD detection using the Mahalanobis distance. To better account for class-dependent variability in histological data, we propose the use of class-specific thresholds. We optimize the thresholds using the mean of the false negative and false positive rates, resulting in only 0.16\% of pathological tissue classified as healthy and 0.35\% of healthy tissue classified as pathological. Applied to mouse liver WSIs with known toxicological findings, the framework accurately detects anomalies, including rare OOD morphologies. This work demonstrates the potential of AI-driven histopathology to support preclinical workflows, reduce late-stage failures, and improve efficiency in drug development.

A texture-based framework for foundational ultrasound models

Ultrasound is the most widely used medical imaging modality, yet the images it produces are fundamentally unique, arising from tissue-dependent scattering, reflection, and speed-of-sound variations that produce a constrained set of characteristic textures that differ markedly from natural-image statistics. These acoustically driven patterns make ultrasound challenging for algorithms originally designed for natural images. To bridge this gap, the field has increasingly turned to foundation models, hoping to leverage their generalization capabilities. However, these models often falter in ultrasound applications because they are not designed for ultrasound physics, they are merely trained on ultrasound data. Therefore, it is essential to integrate ultrasound-specific domain knowledge into established learning frameworks. We achieve this by reformulating self-supervised learning as a texture-analysis problem, introducing texture ultrasound semantic analysis (TUSA). Using TUSA, models learn to leverage highly scalable contrastive methods to extract true domain-specific representations directly from simple B-mode images. We train a TUSA model on a combination of open-source, simulated, and in vivo data. The latent space is compared to several larger foundation models, demonstrating that our approach gives TUSA models better generalizability for difficult downstream tasks on unique online datasets as well as a clinical eye dataset collected for this study. Our model achieves higher accuracy in detecting COVID (70%), spinal hematoma (100%) and vitreous hemorrhage (97%) and correlates more closely with quantitative parameters like liver steatosis (r = 0.83), ejection fraction (r = 0.63), and oxygen saturation (r = 0.38). We open-source the model weights and training script: https://github.com/talg2324/tusa

DINO-AD: Unsupervised Anomaly Detection with Frozen DINO-V3 Features

Unsupervised anomaly detection (AD) in medical images aims to identify abnormal regions without relying on pixel-level annotations, which is crucial for scalable and label-efficient diagnostic systems. In this paper, we propose a novel anomaly detection framework based on DINO-V3 representations, termed DINO-AD, which leverages self-supervised visual features for precise and interpretable anomaly localization. Specifically, we introduce an embedding similarity matching strategy to select a semantically aligned support image and a foreground-aware K-means clustering module to model the distribution of normal features. Anomaly maps are then computed by comparing the query features with clustered normal embeddings through cosine similarity. Experimental results on both the Brain and Liver datasets demonstrate that our method achieves superior quantitative performance compared with state-of-the-art approaches, achieving AUROC scores of up to 98.71. Qualitative results further confirm that our framework produces clearer and more accurate anomaly localization. Extensive ablation studies validate the effectiveness of each proposed component, highlighting the robustness and generalizability of our approach.

TempDiffReg: Temporal Diffusion Model for Non-Rigid 2D-3D Vascular Registration

Transarterial chemoembolization (TACE) is a preferred treatment option for hepatocellular carcinoma and other liver malignancies, yet it remains a highly challenging procedure due to complex intra-operative vascular navigation and anatomical variability. Accurate and robust 2D-3D vessel registration is essential to guide microcatheter and instruments during TACE, enabling precise localization of vascular structures and optimal therapeutic targeting. To tackle this issue, we develop a coarse-to-fine registration strategy. First, we introduce a global alignment module, structure-aware perspective n-point (SA-PnP), to establish correspondence between 2D and 3D vessel structures. Second, we propose TempDiffReg, a temporal diffusion model that performs vessel deformation iteratively by leveraging temporal context to capture complex anatomical variations and local structural changes. We collected data from 23 patients and constructed 626 paired multi-frame samples for comprehensive evaluation. Experimental results demonstrate that the proposed method consistently outperforms state-of-the-art (SOTA) methods in both accuracy and anatomical plausibility. Specifically, our method achieves a mean squared error (MSE) of 0.63 mm and a mean absolute error (MAE) of 0.51 mm in registration accuracy, representing 66.7\% lower MSE and 17.7\% lower MAE compared to the most competitive existing approaches. It has the potential to assist less-experienced clinicians in safely and efficiently performing complex TACE procedures, ultimately enhancing both surgical outcomes and patient care. Code and data are available at: \textcolor{blue}{https://github.com/LZH970328/TempDiffReg.git}

Motif Diversity in Human Liver ChIP-seq Data Using MAP-Elites

Motif discovery is a core problem in computational biology, traditionally formulated as a likelihood optimization task that returns a single dominant motif from a DNA sequence dataset. However, regulatory sequence data admit multiple plausible motif explanations, reflecting underlying biological heterogeneity. In this work, we frame motif discovery as a quality-diversity problem and apply the MAP-Elites algorithm to evolve position weight matrix motifs under a likelihood-based fitness objective while explicitly preserving diversity across biologically meaningful dimensions. We evaluate MAP-Elites using three complementary behavioral characterizations that capture trade-offs between motif specificity, compositional structure, coverage, and robustness. Experiments on human CTCF liver ChIP-seq data aligned to the human reference genome compare MAP-Elites against a standard motif discovery tool, MEME, under matched evaluation criteria across stratified dataset subsets. Results show that MAP-Elites recovers multiple high-quality motif variants with fitness comparable to MEME's strongest solutions while revealing structured diversity obscured by single-solution approaches.

Robust Multicentre Detection and Classification of Colorectal Liver Metastases on CT: Application of Foundation Models

Colorectal liver metastases (CRLM) are a major cause of cancer-related mortality, and reliable detection on CT remains challenging in multi-centre settings. We developed a foundation model-based AI pipeline for patient-level classification and lesion-level detection of CRLM on contrast-enhanced CT, integrating uncertainty quantification and explainability. CT data from the EuCanImage consortium (n=2437) and an external TCIA cohort (n=197) were used. Among several pretrained models, UMedPT achieved the best performance and was fine-tuned with an MLP head for classification and an FCOS-based head for lesion detection. The classification model achieved an AUC of 0.90 and a sensitivity of 0.82 on the combined test set, with a sensitivity of 0.85 on the external cohort. Excluding the most uncertain 20 percent of cases improved AUC to 0.91 and balanced accuracy to 0.86. Decision curve analysis showed clinical benefit for threshold probabilities between 0.30 and 0.40. The detection model identified 69.1 percent of lesions overall, increasing from 30 percent to 98 percent across lesion size quartiles. Grad-CAM highlighted lesion-corresponding regions in high-confidence cases. These results demonstrate that foundation model-based pipelines can support robust and interpretable CRLM detection and classification across heterogeneous CT data.

Stage-specific cancer survival prediction enriched by explainable machine learning

Despite the fact that cancer survivability rates vary greatly between stages, traditional survival prediction models have frequently been trained and assessed using examples from all combined phases of the disease. This method may result in an overestimation of performance and ignore the stage-specific variations. Using the SEER dataset, we created and verified explainable machine learning (ML) models to predict stage-specific cancer survivability in colorectal, stomach, and liver cancers. ML-based cancer survival analysis has been a long-standing topic in the literature; however, studies involving the explainability and transparency of ML survivability models are limited. Our use of explainability techniques, including SHapley Additive exPlanations (SHAP) and Local Interpretable Model-agnostic Explanations (LIME), enabled us to illustrate significant feature-cancer stage interactions that would have remained hidden in traditional black-box models. We identified how certain demographic and clinical variables influenced survival differently across cancer stages and types. These insights provide not only transparency but also clinical relevance, supporting personalized treatment planning. By focusing on stage-specific models, this study provides new insights into the most important factors at each stage of cancer, offering transparency and potential clinical relevance to support personalized treatment planning.

Early Prediction of Liver Cirrhosis Up to Three Years in Advance: A Machine Learning Study Benchmarking Against the FIB-4 Score

Objective: Develop and evaluate machine learning (ML) models for predicting incident liver cirrhosis one, two, and three years prior to diagnosis using routinely collected electronic health record (EHR) data, and to benchmark their performance against the FIB-4 score. Methods: We conducted a retrospective cohort study using de-identified EHR data from a large academic health system. Patients with fatty liver disease were identified and categorized into cirrhosis and non-cirrhosis cohorts based on ICD-9/10 codes. Prediction scenarios were constructed using observation and prediction windows to emulate real-world clinical use. Demographics, diagnoses, laboratory results, vital signs, and comorbidity indices were aggregated from the observation window. XGBoost models were trained for 1-, 2-, and 3-year prediction horizons and evaluated on held-out test sets. Model performance was compared with FIB-4 using area under the receiver operating characteristic curve (AUC). Results: Final cohorts included 3,043 patients for the 1-year prediction, 1,981 for the 2-year prediction, and 1,470 for the 3-year prediction. Across all prediction windows, ML models consistently outperformed FIB-4. The XGBoost models achieved AUCs of 0.81, 0.73, and 0.69 for 1-, 2-, and 3-year predictions, respectively, compared with 0.71, 0.63, and 0.57 for FIB-4. Performance gains persisted with longer prediction horizons, indicating improved early risk discrimination. Conclusions: Machine learning models leveraging routine EHR data substantially outperform the traditional FIB-4 score for early prediction of liver cirrhosis. These models enable earlier and more accurate risk stratification and can be integrated into clinical workflows as automated decision-support tools to support proactive cirrhosis prevention and management.